Suppression of lncRNA HOXA11-AS/miR-124 Axis Inhibits Glioma Progression

Ostrom, Q. T., Gittleman, H., Fulop, J., Liu, M., Blanda, R., Kromer, C., Wolinsky, Y., Kruchko, C. & Barnholtz-Sloan, J. S. (2015). CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2008-2012. Neuro-Oncology, 17(Suppl 4), iv1–iv62 Louis, D. N., Ohgaki, H., Wiestler, O. D., Cavenee, W. K., Burger, P. C., Jouvet, A., Scheithauer, B. W., & Kleihues, P. (2007). The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathologica, 114(2), 97–109 Ma, C. C., Xiong, Z., Zhu, G. N., Wang, C., Zong, G., Wang, H. L., Bian, E. B., & Zhao, B. (2016). Long non-coding RNA ATB promotes glioma malignancy by negatively regulating miR-200a. Journal of Experimental & Clinical Cancer Research, 35(1), 90 Gurley, S. N., Abidi, A. H., Allison, P., Guan, P., Duntsch, C., Robertson, J. H., Kosanke, S. D., Keir, S. T., Bigner, D. D., & Elberger, A. J., et al. (2012). Mechanism of anti-glioma activity and in vivo efficacy of the cannabinoid ligand KM-233. Journal of Neuro-Oncology, 110(2), 163–177 Hatanpaa, K. J., Burma, S., Zhao, D., & Habib, A. A. (2010). Epidermal growth factor receptor in glioma: signal transduction, neuropathology, imaging, and radioresistance. Neoplasia, 12(9), 675–684 Endersby, R., & Baker, S. J. (2008). PTEN signaling in brain: neuropathology and tumorigenesis. Oncogene, 27(41), 5416–5430 Kapranov, P., Cheng, J., Dike, S., Nix, D. A., Duttagupta, R., Willingham, A. T., Stadler, P. F., Hertel, J., Hackermuller, J., & Hofacker, I. L., et al. (2007). RNA maps reveal new RNA classes and a possible function for pervasive transcription. Science, 316(5830), 1484–1488 Tripathi, V., Ellis, J. D., Shen, Z., Song, D. Y., Pan, Q., Watt, A. T., Freier, S. M., Bennett, C. F., Sharma, A., & Bubulya, P. A., et al. (2010). The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. Molecular Cell, 39(6), 925–938 Richards, E. J., Permuth-Wey, J., Li, Y., Chen, Y. A., Coppola, D., Reid, B. M., Lin, H. Y., Teer, J. K., Berchuck, A., & Birrer, M. J., et al. (2015). A functional variant in HOXA11-AS, a novel long non-coding RNA, inhibits the oncogenic phenotype of epithelial ovarian cancer. Oncotarget, 6(33), 34745–34757 Wang, Q., Zhang, J., Liu, Y., Zhang, W., Zhou, J., Duan, R., Pu, P., Kang, C., & Han, L. (2016). A novel cell cycle-associated lncRNA, HOXA11-AS, is transcribed from the 5-prime end of the HOXA transcript and is a biomarker of progression in glioma. Cancer Letters, 373(2), 251–259 Salmena, L., Poliseno, L., Tay, Y., Kats, L., & Pandolfi, P. P. (2011). A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell, 146(3), 353–358 Ma, M. Z., Zhang, Y., Weng, M. Z., Wang, S. H., Hu, Y., Hou, Z. Y., Qin, Y. Y., Gong, W., Zhang, Y. J., & Kong, X., et al. (2016). Long noncoding RNA GCASPC, a target of miR-17-3p, negatively regulates pyruvate carboxylase-dependent cell proliferation in gallbladder cancer. Cancer Research, 76(18), 5361–5371 Li, A., Lin, X., Tan, X., Yin, B., Han, W., Zhao, J., Yuan, J., Qiang, B., & Peng, X. (2013). Circadian gene clock contributes to cell proliferation and migration of glioma and is directly regulated by tumor-suppressive miR-124. FEBS Letters, 587(15), 2455–2460 Lv, Z., & Yang, L. (2013). MiR-124 inhibits the growth of glioblastoma through the downregulation of SOS1. Molecular Medicine Reports, 8(2), 345–349 Chen, F., Feng, Z., Zhu, J., Liu, P., Yang, C., Huang, R., & Deng, Z. (2018). Emerging roles of circRNA_NEK6 targeting miR-370-3p in the proliferation and invasion of thyroid cancer via Wnt signaling pathway. Cancer Biology & Therapy, 19(12), 1139–1152 Li, Y., Li, S., Luo, Y., Liu, Y., & Yu, N. (2017). LncRNA PVT1 regulates chondrocyte apoptosis in osteoarthritis by acting as a sponge for miR-488-3p. DNA and Cell Biology, 36(7), 571–580 Xu, F., & Zhang, J. (2017). Long non-coding RNA HOTAIR functions as miRNA sponge to promote the epithelial to mesenchymal transition in esophageal cancer. Biomedicine & Pharmacotherapy, 90, 888–896 Huarte, M. (2015). The emerging role of lncRNAs in cancer. Nature Medicine, 21(11), 1253–1261 Zhang, X. Q., & Leung, G. K. (2014). Long non-coding RNAs in glioma: functional roles and clinical perspectives. Neurochemistry International, 77, 78–85 Zhang, X., Xu, Y., He, C., Guo, X., Zhang, J., He, C., Zhang, L., Kong, M., Chen, B., & Zhu, C. (2015). Elevated expression of CCAT2 is associated with poor prognosis in esophageal squamous cell carcinoma. Journal of Surgical Oncology, 111(7), 834–839 Wu, F., Zhang, C., Cai, J., Yang, F., Liang, T., Yan, X., Wang, X., Wang, W., Chen, J., & Jiang, T. (2017). Upregulation of long noncoding RNA HOXA-AS3 promotes tumor progression and predicts poor prognosis in glioma. Oncotarget, 8(32), 53110–53123 Wang, Q., Li, Q., Zhou, P., Deng, D., Xue, L., Shao, N., Peng, Y., & Zhi, F. (2017). Upregulation of the long non-coding RNA SNHG1 predicts poor prognosis, promotes cell proliferation and invasion, and reduces apoptosis in glioma. Biomedicine & Pharmacotherapy, 91, 906–911 Zeng, J., Du, T., Song, Y., Gao, Y., Li, F., Wu, R., Chen, Y., Li, W., Zhou, H., Yang, Y., et al. (2016). Knockdown of long noncoding RNA CCAT2 inhibits cellular proliferation, invasion, and EMT in glioma cells. Oncology Research, 25(6), 913–921 Sun, M., Nie, F., Wang, Y., Zhang, Z., Hou, J., He, D., Xie, M., Xu, L., De, W., & Wang, Z., et al. (2016). LncRNA HOXA11-AS promotes proliferation and invasion of gastric cancer by scaffolding the chromatin modification factors PRC2, LSD1, and DNMT1. Cancer Research, 76(21), 6299–6310 Liu, Z., Chen, Z., Fan, R., Jiang, B., Chen, X., Chen, Q., Nie, F., Lu, K., & Sun, M. (2017). Over-expressed long noncoding RNA HOXA11-AS promotes cell cycle progression and metastasis in gastric cancer. Molecular Cancer, 16(1), 82 Kim, H. J., Eoh, K. J., Kim, L. K., Nam, E. J., Yoon, S. O., Kim, K. H., Lee, J. K., Kim, S. W., & Kim, Y. T. (2016). The long noncoding RNA HOXA11 antisense induces tumor progression and stemness maintenance in cervical cancer. Oncotarget, 7(50), 83001–83016 Chen, J. H., Zhou, L. Y., Xu, S., Zheng, Y. L., Wan, Y. F., & Hu, C. P. (2017). Overexpression of lncRNA HOXA11-AS promotes cell epithelial-mesenchymal transition by repressing miR-200b in non-small cell lung cancer. Cancer Cell International, 17, 64 Chandrasekar, V., & Dreyer, J. L. (2009). microRNAs miR-124, let-7d and miR-181a regulate cocaine-induced plasticity. Molecular and Cellular Neuroscience, 42(4), 350–362 Wang, X., Wu, Q., Xu, B., Wang, P., Fan, W., Cai, Y., Gu, X., & Meng, F. (2015). MiR-124 exerts tumor suppressive functions on the cell proliferation, motility and angiogenesis of bladder cancer by fine-tuning UHRF1. The FEBS Journal, 282(22), 4376–4388 Wu, S., Shen, W., Pan, Y., Zhu, M., Xie, K., Geng, L., Wang, Y., Liang, Y., Xu, J., & Cao, S., et al. (2015). Genetic variations in key MicroRNAs are associated with the survival of nonsmall cell lung cancer. Medicine, 94(47), e2084 Maher, E. A., Furnari, F. B., Bachoo, R. M., Rowitch, D. H., Louis, D. N., Cavenee, W. K., & DePinho, R. A. (2001). Malignant glioma: genetics and biology of a grave matter. Genes & Development, 15(11), 1311–1333 Cui, M., Wang, J., Li, Q., Zhang, J., Jia, J., & Zhan, X. (2017). Long non-coding RNA HOXA11-AS functions as a competing endogenous RNA to regulate ROCK1 expression by sponging miR-124-3p in osteosarcoma. Biomedicine & Pharmacotherapy, 92, 437–444